Back to results
US 2023/0145868 A1Published application
Urea inhibitors of micro-rna
OwnerGeorge CALIN, Philip JONES +2inventors
InventorsGeorge CALIN, Philip JONES, Barbara CZAKO, Simone ANFOSSI
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds and methods which may be useful as inhibitors of the expression of miRNA, for use in the treatment or prevention of cancer.
Claims67
A compound of structural Formula I:
- or a salt or tautomer thereof, wherein:
- W1 is chosen from CR4 and N;
- W2 is chosen from CR5 and N;
- W3 is chosen from CR6 and N;
- Z1 is chosen from CR7 and N;
- Z2 is chosen from CR8 and N;
- Z3 is chosen from CR9 and N;
- R1 and R2 are independently chosen from H, CN, NH2, OH, and halo;
- R3 is chosen from H, CN, halo, hydroxy, alkyl, and alkoxy;
- R4 is chosen from H, CN, halo, alkyl, and alkoxy;
- or R4, if present, and R3, together with the intervening carbons, can form a 5-, 6-, or 7-membered cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring optionally substituted with one or more R19;
- R5, R6, R7, R8, and R9 are independently chosen from H, CN, halo, alkyl, and alkoxy;
- and
- each R19 is independently chosen from CN, halo, OH, NH2, and oxo.
11 more elements
The compound as recited in either one of claims 51 and 52, or a salt or tautomer thereof, wherein W2 and W3 are CH.
Dependencies are inferred from the claim text.